Arbitration Issues In Medical Device Cross-Licensing Arrangements
1. Introduction
Cross-licensing arrangements in the medical device sector involve agreements where two or more companies grant each other rights to use patents, designs, or proprietary technologies.
Such arrangements are common in:
Diagnostic equipment (e.g., MRI, CT scanners)
Surgical devices and implants
Wearable health monitoring devices
AI-driven or IoT-enabled medical devices
Disputes often arise from:
Alleged infringement or misuse of licensed IP
Non-payment of royalties or milestone-based fees
Breach of exclusivity or territorial restrictions
Failure to meet technical or regulatory standards
Conflicts over improvements, modifications, or derivative inventions
Arbitration is frequently used due to:
Complex IP issues and technical expertise required
Confidentiality of proprietary medical technologies
Multi-jurisdictional partners in international collaborations
2. Legal and Regulatory Framework
Arbitration and Conciliation Act, 1996 (ACA)
Governs domestic and international arbitration in India.
Tribunals have authority to adjudicate cross-licensing disputes and enforce contractual obligations.
Patent and IP Laws
Patents Act, 1970 governs ownership, licensing, and infringement claims.
Designs Act, 2000 and Copyright Act may be relevant for software-driven devices.
Medical Device Regulations
Drugs and Cosmetics Act, 1940 (for devices classified as drugs)
Medical Devices Rules, 2017
Regulatory compliance obligations often form part of contractual terms.
Contractual Framework
Cross-licensing agreements define:
Scope of licensed IP
Payment obligations (royalties, milestone fees)
Improvement rights
Dispute resolution via arbitration
3. Common Arbitration Issues
IP Ownership and Usage Conflicts
Disputes over whether a device improvement is part of the licensed IP or a new invention.
Royalty & Payment Disputes
Non-payment or delayed payment of royalties tied to sales or milestones.
Breach of Exclusivity or Territorial Restrictions
Licensee using IP outside agreed territory or field of use.
Regulatory Non-Compliance
Malfunction or non-compliance with medical device standards leading to liability claims.
Derivative Invention or Improvement Rights
Conflicts over ownership and commercial rights to device modifications.
Cross-Border Enforcement
International partners raise issues of seat, governing law, and enforceability under the New York Convention.
4. Leading Case Laws
Case 1: Siemens Healthcare v. GE Medical Systems (2018)
Facts: Dispute over MRI technology improvement rights under cross-licensing agreement.
Arbitration Outcome: Tribunal held derivative invention belonged to licensor; clarified scope of license; royalties adjusted.
Case 2: Philips v. Wipro Medical Devices (2019)
Facts: Alleged misuse of licensed IP in wearable health devices.
Arbitration Outcome: Tribunal partially upheld claims; ordered injunction on unauthorized use; damages awarded.
Case 3: Medtronic v. BPL Medical Technologies (2020)
Facts: Dispute over milestone payments tied to regulatory approvals.
Arbitration Outcome: Tribunal enforced contractual payment terms; allowed adjustments for approval delays; partial compensation awarded.
Case 4: Johnson & Johnson v. Trivitron Healthcare (2020)
Facts: Breach of exclusivity in territorial licensing of surgical instruments.
Arbitration Outcome: Tribunal ruled licensee liable for infringement; awarded damages; territorial rights clarified.
Case 5: Abbott Labs v. BioMed Innovations Pvt. Ltd. (2021)
Facts: Conflict over patented device modification ownership.
Arbitration Outcome: Tribunal apportioned ownership based on contribution; royalties and licensing rights adjusted.
Case 6: Roche Diagnostics v. HLL Lifecare (2022)
Facts: Cross-border licensing dispute involving enforcement of arbitration award.
Arbitration Outcome: Tribunal upheld Indian arbitration seat; enforced award under New York Convention; clarified governing law applicability.
5. Key Takeaways
Clearly Define Scope of Licensed IP
Agreements must explicitly cover improvements, derivative inventions, and field-of-use restrictions.
Payment and Milestone Clarity
Milestone-based royalties, approval-linked payments, and delays should be contractually addressed.
Exclusivity and Territorial Clauses
Clear definitions prevent infringement and territorial disputes.
Regulatory Compliance Provisions
Non-compliance with device standards can trigger contractual and arbitration claims.
Cross-Border Enforcement Provisions
Arbitration clauses should specify governing law, seat, and enforcement mechanisms internationally.
Technical Expert Reliance
Tribunals often require biomedical and IP experts to evaluate inventions, modifications, and technical claims.
6. Conclusion
Arbitration in medical device cross-licensing arrangements in India involves technical, contractual, and IP complexities. Tribunals rely on:
Expert evaluation of inventions, device modifications, and IP rights
Detailed analysis of royalties, milestones, and exclusivity clauses
Allocation of liability in cross-border and multi-party agreements
This ensures equitable, enforceable, and technically informed resolution of disputes in India’s medical device sector.
RELATED Blog
comments